The Industry’s Ingredient Bias
The skincare industry has become increasingly ingredient-led. Product development often begins with a hero active and builds outward from there. This approach creates a blind spot. When formulation is driven primarily by ingredients, the underlying structure of the product receives less attention. The base becomes a secondary decision rather than a foundational one. From a formulation perspective, this is where problems begin. This is why skincare formulation systems need to be designed as integrated structures, not assembled components. Their behaviour is defined by the environment they sit in. Without a well-designed system, even the most promising actives become difficult to stabilise, deliver and scale.
What Skincare Formulation Systems Actually Involve
In topical development, a system is not a single component. It is the interaction between multiple elements that together define how a product behaves. This includes the emulsion structure, solvent system, polymer or gelling network, lipid composition, and preservation strategy. Each of these elements influences the others. A change in one part of the system can shift the balance of the entire formulation. This is why formulation is not simply about combining ingredients. It is about designing a structure that can support them.
Skincare formulation systems must be designed with both stability and regulatory compliance in mind.
Why Skincare Formulation Systems Determine Stability and Performance
Stability is often treated as something that is tested at the end of development. In reality, it is established much earlier. The system determines whether an active remains soluble, whether phases remain intact, and whether the product maintains its intended texture and function over time.
Factors such as pH drift, temperature exposure and packaging interaction all place stress on the formulation. A well-designed system absorbs this stress, while a weak one begins to break down. Regulatory frameworks also reinforce this approach, with guidance from bodies such as the U.S. Food and Drug Administration outlining the importance of product safety and stability in cosmetic development.
The Scale-Up Reality Most Brands Underestimate
One of the most challenging transitions in product development is moving from lab scale to manufacturing. Conditions change. Shear forces differ. Batch sizes increase. External variables such as transport and storage come into play. A formulation that appears stable in controlled conditions can behave very differently in production. This is where system design becomes critical. If the structure of the formulation has not been engineered with scale in mind, inconsistencies begin to appear. These are often misattributed to individual ingredients, when the underlying issue is structural.
What This Means for Brand Founders
For brand founders, these formulation decisions have direct commercial consequences. A poorly designed system leads to reformulation cycles, delays in production, and increased costs. It also introduces risk in product consistency, which ultimately affects customer trust. A well-designed system creates the opposite effect. Development timelines become more predictable. Scale-up is smoother. The product maintains its integrity across batches and over time. This is not only a technical advantage. It is a strategic one.
Final Thought
If your product fails stability, scale-up, or consistency, the question to ask is: “Was the base system ever designed to carry what we built on top of it?” At HBM, this is where we begin every formulation conversation, because everything else depends on it.
